<DOC>
	<DOC>NCT01727024</DOC>
	<brief_summary>This study compared the correct use of and patient preference for two drug delivery systems (inhalers) in patients with COPD</brief_summary>
	<brief_title>Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Key 1. Male and female adults aged â‰¥40 years, who have signed an Informed Consent form prior to initiation of any studyrelated procedure. 2. Cooperative outpatients with a diagnosis of moderate COPD as classified by the GOLD Guidelines 2010 or grade A in GOLD 2011and including: Smoking history of at least 10 pack years FEV1/FVC &lt; 70% Key Exclusion criteria: 1. Previous diagnosis of asthma 2. Pregnant or nursing women 3. Hospitalization or emergency room attendance due to COPD exacerbation within 3 months prior to visit 1</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Breezhaler</keyword>
	<keyword>Respimat</keyword>
	<keyword>Indacaterol</keyword>
	<keyword>Tiotropium</keyword>
</DOC>